Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Novel Quinolinylaminoisoquinoline Bioisosteres of Sorafenib as Selective RAFI Kinase Inhibitors: Design, Synthesis, and Antiproliferative Activity against Melanoma Cell Line
- Authors
- Cho, Hye Jung; El-Gamal, Mohammed Ibrahim; Oh, Chang-Hyun; Lee, So Ha; Sim, Taebo; Kim, Garam; Choi, Hong Seok; Choi, Jung Hoon; Yoo, Kyung Ho
- Issue Date
- Jul-2013
- Publisher
- Pharmaceutical Society of Japan
- Keywords
- bioisostere; melanoma; quinolinylaminoisoquinoline; Sorafenib; antiproliferative activity
- Citation
- Chemical and Pharmaceutical Bulletin, v.61, no.7, pp 747 - 756
- Pages
- 10
- Indexed
- SCIE
SCOPUS
- Journal Title
- Chemical and Pharmaceutical Bulletin
- Volume
- 61
- Number
- 7
- Start Page
- 747
- End Page
- 756
- ISSN
- 0009-2363
1347-5223
- Abstract
- Design and synthesis of a new series of quinolinylaminoisoquinoline derivatives as conformationally restricted bioisosteres of Sorafenib are described. Their in vitro antiproliferative activity against A375P melanoma cell line was tested. Compounds 1b, id, 1g, and 1j showed the highest potency against A375P cell line with IC50 values in sub-micromolar scale. In addition, compound id exerted high selectivity towards RAF1 serine/threonine kinase with 96.47% inhibition at 101 mu m, and IC50 of 0.961 mu m. This compound can possess antiproliferative activity against melanoma cells through inhibition of RAF1 kinase.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 교무처 > 서울 창의융합교육원 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.